Abstract:
Liver transplantation (OLTx) has been investigated as a mode of therapy for malignancies. The efficacy of OLTx for the treatment of cholangiocarcinoma (CCA) has been somewhat controversial. We review the current literature on resective procedures for CCA and show that isolated intrahepatic CCA has a slightly better survival than extrahepatic disease. Results of OLTx for CCA are then reviewed, with specific attention to the experience at our center. Our results demonstrate that 1-year patient survival was 53%, and disease-free survival at 3 years was only 13%. Specific issues pertaining to the timing of OLTx in primary sclerosing cholangitis are then addressed. In summary, we believe that OLTx for known CCA results in a very poor patient survival. Those with incidental CCA found on explant histopathologic evaluation, without lymphatic involvement, may result in acceptable patient survival.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received for publication on June 6, 1997; accepted on July 7, 1997
About this article
Cite this article
Jeyarajah, D., Klintmalm, G. Is liver transplantation indicated for cholangiocarcinoma?. J Hep Bil Pancr Surg 5, 48–51 (1998). https://doi.org/10.1007/PL00009950
Issue Date:
DOI: https://doi.org/10.1007/PL00009950